Assenagon Asset Management S.A. Enzo Biochem Inc Transaction History

Assenagon Asset Management S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$1.21 - $1.5 $63,698 - $78,964	-52,643 Reduced 72.7%	19,773 $25,000
Q4 2023 Jan 17, 2024	SELL	$1.21 - $1.44 $10,625 - $12,644	-8,781 Reduced 10.81%	72,416 $100,000
Q3 2023 Nov 06, 2023	SELL	$1.3 - $1.87 $130,864 - $188,243	-100,665 Reduced 55.35%	81,197 $113,000
Q2 2023 Jul 25, 2023	BUY	$1.84 - $2.66 $194,381 - $281,007	105,642 Added 138.6%	181,862 $334,000
Q1 2023 Apr 18, 2023	BUY	$1.0 - $2.51 $76,220 - $191,312	76,220 New	76,220 $185,000
Q2 2022 Jul 27, 2022	BUY	$2.0 - $3.0 $39,206 - $58,809	19,603 New	19,603 $41,000
Q3 2021 Oct 19, 2021	SELL	$3.01 - $3.77 $35,496 - $44,459	-11,793 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$2.86 - $3.61 $33,727 - $42,572	11,793 New	11,793 $37,000
Q2 2019 Aug 12, 2019	SELL	$2.79 - $4.31 $215,703 - $333,219	-77,313 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$2.54 - $4.02 $103,482 - $163,778	40,741 Added 111.4%	77,313 $211,000
Q4 2018 Jan 23, 2019	SELL	$2.46 - $4.2 $96,948 - $165,522	-39,410 Reduced 51.87%	36,572 $102,000
Q3 2018 Oct 29, 2018	BUY	$3.81 - $5.53 $289,491 - $420,180	75,982 New	75,982 $313,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $52.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.